Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
18 drugs in development
By Therapeutic Area
top 6
R&D Momentum
80/100
Pipeline Velocity
47/100
Trial Completion Rate
72/100
Pipeline Concentration
12/100
Pipeline Freshness
58/100
Strategic Signals
Activity
Last 14 days
A Randomized Trial of Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients With Acute Heart Failure
Randomized Trial Comparing Parallel Versus Perpendicular Technique for Lumbar Medial Branch Radiofrequency Neurotomy
Vagal Stimulation in POTS - The Autonomic Inflammatory Reflex (Pilot 3)
Hyperangulated Versus Standard Geometry Laryngoscope Blade Trial
Deformable Tissue Modelling and Augmented Reality Based Guidance for Head and Neck Tumor Re-Resection Task
Comparing Placebo Versus Antibiotics for Acute Uncomplicated Diverticulitis
Dietary Sodium Inflammation and Salt Sensitivity of Blood Pressure
Massage Percussion Therapy for Passage of Urolithiasis Fragments After Ureteroscopy
Utility of PCD Diagnostics to Improve Clinical Care
Improving Diagnostic Accuracy for Acute Heart Failure
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)